Publication | Closed Access

Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages

AsthmaInflammationAcute Lung InjuryInflammatory ResponsesAnti-inflammatoryInflammatory Lung DiseaseLung InflammationM2 MacrophagesMedicineImmunologyCell DeathChronic InflammationGinsenoside Rg1Pulmonary PharmacologyPhagocytePharmacologyOxidative Stress